Sharps (STSS) Revenue & Revenue Breakdown
Sharps Revenue Highlights
0
Latest Revenue (Q)
$83.62K
Sharps Revenue by Period
Sharps Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Sharps generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Sharps Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $83.62K | -62.45% |
| 2025-06-30 | $222.72K | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $-8.23K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $8.23K | -200.00% |
| 2023-12-31 | $-8.23K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $8.23K | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $-14.90K | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Sharps generated $83.62K in revenue during Q3 2025, up -62.45% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Sharps Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| JYNT | Joint | $51.90T | $13.38M |
| LUCD | Lucid Diagnostics | $4.35B | $1.21B |
| CCLD | CareCloud | $110.84M | $31.07M |
| PDEX | Pro-Dex | $66.59M | $18.53M |
| RPID | Rapid Micro Biosystems | $28.05M | $7.84M |
| SERA | Sera Prognostics | $77.00K | $17.00K |
| MBOT | Microbot Medical | - | - |
| CGTX | Cognition Therapeutics | - | - |
| STSS | Sharps | - | $83.62K |
| GLSI | Greenwich LifeSciences | - | - |
| IXHL | Incannex Healthcare | - | - |